Loading market dashboard
Elevance Health Inc.
ELVHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Elevance Health, Inc. has rebounded ~34% from its March lows, supported by sector recovery and improved Q1 2026 results. Q1 2026 saw ELV revenue up 1.5% to $49.5bn, adjusted EPS up 5.1% to $12.58, and a benefit expense ratio improvement to 86.8%. ELV raised 2026 adjusted EPS guidance to at least $26.75 and expects a return to 12% adjusted EPS growth in 2027.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is advancing its commitment to improving healthcare access by addressing one of healthcare's most pressing challenges: the digital divide. Through innovative programs like Get Connected for Health and services offered by CareBridge, a subsidiary of Elevance Health, the company is helping ensure that individuals - especially those in underserved communities - have the tools, connectivity, and support needed to help them better manage their healthcar.
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.
On May 19, 2026, we present a detailed DCF analysis for Elevance Health Inc (ELV), a company currently trading at $394.07. The stock has shown a strong price pe
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
On May 12, 2026, Elevance Health Inc (ELV) shares rose 4.0% today, bringing the current price to $393.30. The stock has experienced a 52-week range between $273
On May 12, 2026, we present a DCF analysis for Elevance Health Inc (ELV), a company currently trading at $381.75. The stock has shown mixed performance, with a
On May 08, 2026, we conducted a DCF analysis for Elevance Health Inc (ELV) to assess its intrinsic value in the context of its recent price performance. Over th
Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.
Don Lair writes about options income, dividend strategy, and the kind of boring-but-durable investing that actually funds retirement.
INDIANAPOLIS--(BUSINESS WIRE)--Despite growing awareness, mental health concerns remain difficult to navigate and often lead to avoidable crises, costly emergency room visits, and long-term strain on individuals, families, and an already overburdened healthcare system. With nearly one in five Americans experiencing a diagnosable mental health condition each year, the need for funding and systemic improvement has never been greater. That's why Elevance Health is focused on addressing some of the.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, along with its affiliated health plans, today announced 45 distinguished medical practices and health systems to be honored in its annual Care Provider Recognition Program. The program spotlights the top one percent of primary care providers in Elevance Health's nationwide affiliated health plan network of about 7,200 value-based care and evaluated provider partners. The recognition highlights primary care providers who exhibit excellence in deliv.
INDIANAPOLIS--(BUSINESS WIRE)--As small businesses continue to face rising healthcare costs, Elevance Health's affiliated health plans are delivering solutions that help employers offer competitive benefits, improve health outcomes, and keep costs more affordable and more predictable. Recent research shows small businesses and their employees have experienced healthcare cost increases of 26% over the past five years, underscoring the need for more stable and predictable solutions. Small busines.
Comerica Bank lessened its holdings in Elevance Health, Inc. (NYSE: ELV) by 6.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,056 shares of the company's stock after selling 2,331 shares during the period. Comerica Bank's holdings
CNC tops Q1 estimates on strong premiums, lifts 2026 outlook with higher revenue and EPS guidance despite membership decline and rising costs.
Universal Health tops Q1 estimates as behavioral health admissions and patient days rise, driving revenue growth despite higher operating costs.
Looking for broad exposure to the Healthcare - Healthcare - Providers segment of the equity market? You should consider the iShares U.S. Healthcare Providers ETF (IHF), a passively managed exchange traded fund launched on May 1, 2006.
On April 27, 2026, Elevance Health Inc (ELV) shares rose 3.3% to $356.13, continuing a strong performance with a 1-week gain of 11.5% and a 1-month increase of
Cornerstone Investment Partners LLC trimmed its position in Elevance Health, Inc. (NYSE: ELV) by 1.3% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 167,102 shares of the company's stock after selling 2,136 shares during the period. Elevance Health
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE:ELV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.
Elevance Health beats Q1 EPS estimates as net investment income jumps 29.7%, offsetting membership decline and higher expenses.
Elevance Health, Inc. (ELV) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elevance Health (ELV) came out with quarterly earnings of $12.58 per share, beating the Zacks Consensus Estimate of $10.68 per share. This compares to earnings of $11.97 per share a year ago.
Elevance Health Wednesday reported nearly $1.8 billion in first quarter net income as costs continued to be a drag on earnings of the nation's second-largest health insurance company.
Elevance Health raised its annual profit forecast on Wednesday, as it looks to keep medical costs in check.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2026 results ahead of expectations. "Our first quarter results exceeded expectations, reflecting underlying business strength and improving claims experience. We are raising our full-year adjusted EPS guidance, supported by greater visibility into the balance of the year. Our actions are driving more consistent performance and position Elevance Health for continued improvement over time.” Gail K. Boudreaux P.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options
Patriot Financial Group Insurance Agency LLC lessened its stake in Elevance Health, Inc. (NYSE: ELV) by 67.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,433 shares of the company's stock after selling 3,029 shares during the period.
KBC Group NV lessened its position in Elevance Health, Inc. (NYSE: ELV) by 30.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,979 shares of the company's stock after selling 34,367 shares during the period. KBC Group
Beyond analysts' top-and-bottom-line estimates for Elevance Health (ELV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE:ELV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 2, 2026, Elevance disclosed in a filing with the U.S. Securities and Exchange Commission that it “was not.
ELV heads into its April 22 Q1 report with EPS likely down 11.4% as Health Benefits operating income is projected to plunge 13.7% year over year.
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.
UNH's integrated Optum engine and earnings stability give it an edge over ELV as shifting costs and policy changes reshape managed care dynamics.
Elevance Health (NYSE:ELV) stock surged this week after the Centers for Medicare & Medicaid Services finalized a 2.48% Medicare Advantage payment rate increase for 2027, coming in above the high end of the 1% to 2% improvement the market was expecting.
Asio Capital LLC grew its position in shares of Elevance Health, Inc. (NYSE: ELV) by 16.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,457 shares of the company's stock after buying an additional 2,979 shares during the quarter.
CMS confirmed that Medicare Advantage and Part D plans will receive a 2.48% average rate increase for 2027, according to Reuters. Officials also noted that insurers will see an additional 2.5% boost tied to changes in risk‑adjustment calculations, pushing the effective increase closer to 5%.
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly 1% street expectation.
Elevance Health, Inc. is rated a Buy, with valuation now compelling after significant underperformance versus the S&P 500. Despite fundamental headwinds—declining membership, higher benefit expense ratios, and muted guidance—ELV targets 12% annual adjusted EPS growth long-term. Shares are deeply discounted, trading below fair value on both P/E and price-to-sales metrics, with technicals suggesting a potential bottom.
The April 2026 Top 25 High Growth Dividend Stocks list targets quality companies trading below intrinsic value, averaging a 1.52% yield and 17.7% five-year dividend growth. Screened stocks appear ~34% undervalued by dividend yield theory, with an estimated +21% annualized long-term return potential. MSCI, WING, ZTS, INTU, and MSFT stand out for attractive valuations, robust dividend growth, and strong projected EPS growth.
Insurance stocks surged as CMS announced a 2.48% Medicare Advantage payment rate increase for 2027, reversing prior negative sentiment. SpaceX (SPACE) is set to launch its IPO roadshow the week of June 8, with unprecedented retail investor allocation and a target valuation above $2T.
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elevance Health (NYSE: ELV - Get Free Report) and Compass Pathways (NASDAQ: CMPS - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability. Valuation and Earnings This table compares Elevance Health
Elevance Health's decision to shakeup its top management ranks that includes two new finance officers is the latest sign it may take more time for the health insurance industry to rebound.
Elevance Health, Inc. (NYSE: ELV - Get Free Report) was the target of a significant decrease in short interest in March. As of March 13th, there was short interest totaling 3,669,028 shares, a decrease of 13.2% from the February 26th total of 4,227,962 shares. Approximately 1.7% of the company's stock are short sold. Based on an
Elevance Health (NYSE: ELV - Get Free Report) and Selectis Health (OTCMKTS:GBCS - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends. Risk and Volatility Elevance Health has a beta
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) today announced a series of leadership appointments across its Health Benefits and Carelon organizations, positioning the company to strengthen execution, enhance operational performance, and drive continued growth across its businesses. These appointments support the continued expansion of Carelon, Elevance Health's services business, which provides a broad and expanding range of services across care, pharmacy, behavioral health,.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-39.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Canoe Financial LP lessened its holdings in Elevance Health, Inc. (NYSE: ELV) by 4.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 370,662 shares of the company's stock after selling 18,737 shares during the period. Elevance Health makes
Diversified Trust Co. boosted its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 5.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,926 shares of the company's stock after acquiring an additional 1,775 shares during the
Nordea Investment Management AB trimmed its position in shares of Elevance Health, Inc. (NYSE: ELV) by 16.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 340,267 shares of the company's stock after selling 68,527 shares during the quarter. Nordea Investment Management
Elevance Health, Inc. (NYSE: ELV - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twenty-two analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and twelve have issued a buy recommendation on
Brevan Howard Capital Management LP decreased its stake in Elevance Health, Inc. (NYSE: ELV) by 66.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,874 shares of the company's stock after selling 23,597 shares during the period.
Bank of Nova Scotia raised its stake in Elevance Health, Inc. (NYSE: ELV) by 136.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 70,149 shares of the company's stock after purchasing an additional 40,471 shares during the period.
Bridgefront Capital LLC bought a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,905 shares of the company's stock, valued at approximately $616,000. A number of other institutional investors have
